Novel immunotherapeutic molecules and uses thereof
AssigneeAravax Pty Ltd
InventorsRobyn O'Hehir, Jennifer Rolland, Sara Prickett
Life of this patent
Estimating the term…
Loading patent…
AssigneeAravax Pty Ltd
InventorsRobyn O'Hehir, Jennifer Rolland, Sara Prickett
Estimating the term…
The present invention relates generally to molecules such as peptides, polypeptides and proteins which interact immunologically with T lymphocytes in subjects having peanut allergy, or allergy to other tree nuts, and genetic sequences encoding same. These molecules are preferably immunointeractive with T cells in subjects having an allergy to the Ara h 1 allergen. The molecules of the present invention are useful in the development of diagnostic, therapeutic and prophylactic agents for conditions characterised by an aberrant, inappropriate or otherwise unwanted immune response to Ara h 1 or derivative or homologue thereof.
1-34. (canceled)
A method for reducing the severity of Ara h 1 hypersensitivity or sensitivity in a subject to an allergen present in a composition which comprises Ara h 1, said method comprising administering to said subject an effective amount of a composition comprising one or more peptides, wherein said one or more peptides is no more than 28 amino acids in length and comprises an amino acid sequence selected from the group consisting of SEQ ID NO:
(canceled)
(canceled)
-44. (canceled)
Dependencies are inferred from the claim text.